BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3136791)

  • 1. Establishment and characterization of a permanent human IgA2/kappa myeloma cell line.
    Lohmeyer J; Hadam M; Santoso S; Förster W; Schulz A; Pralle H
    Br J Haematol; 1988 Jul; 69(3):335-43. PubMed ID: 3136791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of a human plasma cell myeloma culture having a rearranged cellular myc proto-oncogene.
    Gazdar AF; Oie HK; Kirsch IR; Hollis GF
    Blood; 1986 Jun; 67(6):1542-9. PubMed ID: 2423157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of two new myeloma cell lines from bilateral pleural effusions: evidence for sequential in vivo clonal change.
    Durie BG; Vela E; Baum V; Leibovitz A; Payne CM; Richter LC; Grogan TM; Trent JM
    Blood; 1985 Sep; 66(3):548-55. PubMed ID: 3927997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a novel interleukin-6 autocrine-dependent human plasma cell line.
    Ozaki S; Wolfenbarger D; deBram-Hart M; Kanangat S; Weiss DT; Solomon A
    Leukemia; 1994 Dec; 8(12):2207-13. PubMed ID: 7528862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and characterization of two human myeloma cell lines secreting kappa light chains.
    Eton O; Scheinberg DA; Houghton AN
    Leukemia; 1989 Oct; 3(10):729-35. PubMed ID: 2506399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CALLA-positive leukemic multiple myeloma of IgA-kappa type].
    Matsumura I; Miyata S; Tago H; Kawakami F; Okuno G; Tominaga N; Katagiri S; Kanayama Y; Yonezawa T
    Rinsho Ketsueki; 1989 Apr; 30(4):491-6. PubMed ID: 2504977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of a human IgA-kappa-secreting plasma cell line (MT3).
    Donelli A; Narni F; Tabilio A; Emilia G; Selleri L; Colo A; Zucchini P; Montagnani G; Torelli G; Torelli U
    Int J Cancer; 1987 Sep; 40(3):383-8. PubMed ID: 3114153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracytoplasmic and surface-bound immunoglobulins in "nonsecretory" and Bence-Jones myeloma.
    Preud'Homme JL; Hurez D; Danon F; Brouet JC; Seligmann M
    Clin Exp Immunol; 1976 Sep; 25(3):428-36. PubMed ID: 822974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell surface markers in multiple myeloma.
    Ruiz-Argüelles GJ; San Miguel JF
    Mayo Clin Proc; 1994 Jul; 69(7):684-90. PubMed ID: 8015335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a new human multiple myeloma cell line, UMJF-2, which suppresses antibody production by B-lymphocytes in vitro.
    Farnen JP; Tyrkus M; Hanson CA; Cody RL; Emerson SG
    Leukemia; 1991 Jul; 5(7):574-84. PubMed ID: 1649357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double (IgA kappa + IgG kappa) paraproteinaemia in a single patient: immunofluorescence evidence for a common plasma cell clone 'frozen' at the switch phase.
    Lucivero G; Miglietta A; Dell'Osso A; Theodossiu G; Bonomo L
    Acta Haematol; 1986; 75(4):224-8. PubMed ID: 3096055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human myeloma cell line that does not express immunoglobulin but yields a high frequency of antibody-secreting hybridomas.
    Pickering JW; Gelder FB
    J Immunol; 1982 Jul; 129(1):406-12. PubMed ID: 6806365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and phenotypic characterization of three new human myeloma cell lines (U-1957, U-1958, and U-1996).
    Jernberg H; Nilsson K; Zech L; Lutz D; Nowotny H; Scheirer W
    Blood; 1987 Jun; 69(6):1605-12. PubMed ID: 3580570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-secretory IgA kappa myeloma with distended endoplasmic reticulum: a case report.
    Raubenheimer EJ; Dauth J; Senekal JC
    Histopathology; 1991 Oct; 19(4):380-2. PubMed ID: 1937418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of multiple myeloma with double M-protein peaks for IgG-kappa and IgA-kappa].
    Tadao F; Hayashi M; Ichikawa K; Hirasawa Y; Ohtani H; Saito M; Hatimura K; Oshikawa T; Takayama M; Mori N
    Rinsho Ketsueki; 1984 Oct; 25(10):1646-52. PubMed ID: 6441031
    [No Abstract]   [Full Text] [Related]  

  • 16. The CD24 antigen discriminates between pre-B and B cells in human bone marrow.
    Duperray C; Boiron JM; Boucheix C; Cantaloube JF; Lavabre-Bertrand T; Attal M; Brochier J; Maraninchi D; Bataille R; Klein B
    J Immunol; 1990 Dec; 145(11):3678-83. PubMed ID: 1700990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic and biological characterization of two new human plasma cell lines.
    Brox LW; Belch A; Pollock E; He XX; De Braekeleer M; Lin CC
    Cancer Genet Cytogenet; 1987 Jul; 27(1):135-44. PubMed ID: 3472643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of a human myeloma cell line (KMM-1).
    Togawa A; Inoue N; Miyamoto K; Hyodo H; Namba M
    Int J Cancer; 1982 May; 29(5):495-500. PubMed ID: 7095894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of five human myeloma cell lines.
    Namba M; Ohtsuki T; Mori M; Togawa A; Wada H; Sugihara T; Yawata Y; Kimoto T
    In Vitro Cell Dev Biol; 1989 Aug; 25(8):723-9. PubMed ID: 2768132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biphenotypic plasma cell myeloma: two cases of plasma cell neoplasm with a coexpression of kappa and lambda light chains.
    Jiwani S; Bornhost J; Alapat D
    Int J Clin Exp Pathol; 2015; 8(7):8536-44. PubMed ID: 26339430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.